PHC Holdings Corporation (6523) Cash flow
Market cap
¥132.7B
P/E ratio
66.4x
PHC Holdings operates healthcare companies worldwide, providing diabetes monitoring systems, medical IT solutions, and laboratory equipment across over 110 countries.
| 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Depreciation & amortization | - | - | - | - | - | 27,933 | 27,871 |
| Cash from operations | 33,790 | 36,865 | 47,850 | 51,053 | 21,376 | 41,304 | 41,941 |
| Capital expenditures | -6,766 | -12,733 | -12,154 | -11,736 | -11,516 | -14,630 | -11,610 |
| Cash from investing | -7,415 | -135,467 | -16,314 | -12,521 | -17,520 | -21,072 | -8,473 |
| Repurchases of common stock | -2,762 | -34,715 | -588 | -359 | - | - | - |
| Proceeds from issuance of term debt, net | - | 169,113 | - | 311,348 | - | 62,215 | 1,962 |
| Repayments of term debt | -15,745 | -19,445 | -24,606 | -332,912 | -25,931 | -88,241 | -27,003 |
| Cash from financing | -19,867 | 95,585 | -20,395 | -7,015 | -40,832 | -39,139 | -39,068 |
| Free cash flow | |||||||
| FCF margin (%) |